Surgical removal of the visceral fat mass significantly reduced the risk of intestinal cancer in female mice; however, it failed to increase the levels of adiponectin and reduce the level of glucose, leptin, chemokines, and total adiposity. The gene discussed is ADIPOQ; the disease is intestinal cancer.